首页> 外国专利> Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth

Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth

机译:缓激肽受体1或2的激动剂或拮抗剂在调节侧支血管生长中的治疗用途

摘要

The present invention relates to bradykinin receptor modulators and pharmaceutical compositions thereof for use as a medicament for modulating collateral blood vessel growth of collateral arteries and/or other blood vessels of pre-existing arterial networks. The bradykinin receptor modulators of arteriogenesis are applicable in the treatment and/or prevention of disorders associated with defective blood flow or blood vessel malformation. A preferred aspect of the invention relates to bradykinin receptor agonists for use as a medicament for the prevention of cardiovascular ischemic disease in a patient at risk thereof. Further, the invention relates to a bradykinin receptor agonist for use in a method for treating a cardiovascular ischemic disease in a patient in need thereof, wherein said cardiovascular ischemic disease is a peripheral limb disease.
机译:缓激肽受体调节剂及其药物组合物技术领域本发明涉及缓激肽受体调节剂及其药物组合物,其用作药物以调节侧支动脉和/或先前存在的动脉网的其他血管的侧支血管生长。动脉生成的缓激肽受体调节剂可用于治疗和/或预防与缺陷血流或血管畸形有关的疾病。本发明的一个优选方面涉及缓激肽受体激动剂,其用作在有风险的患者中预防心血管缺血性疾病的药物。此外,本发明涉及一种用于在有需要的患者中治疗心血管缺血性疾病的方法中使用的缓激肽受体激动剂,其中所述心血管缺血性疾病是周围肢体疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号